Private Market View

Hemab Therapeutics Holdings

Drug Discovery · Cambridge, MA · Founded 2019 · In IPO Registration

PA Mark · $/share
$29
Sep 2026
Implied valuation
$386.9M
Total raised
$355.1M
Last round
Later Stage VC (Series C)
Oct 2025
How much has Hemab Therapeutics Holdings raised?
$355.1Macross 2 recorded rounds · Feb 2023Oct 2025

Most recently, Hemab Therapeutics Holdings raised $157.0M in its Later Stage VC (Series C) (Oct 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·The complete investor list — 12 names
  • ·Watchlist + deal alerts for Hemab Therapeutics Holdings
Create free account
No card required

Round by round

2 rounds
Oct 2025Later Stage VC (Series C)$157.0M
+ 1 more investors · free account
Feb 2023Early Stage VC (Series B)$137.8M
+ 1 more investors · free account
For fundraisers
Raising for a company like Hemab Therapeutics Holdings?

12 investors have backed Hemab Therapeutics Holdings — start your target list with the firms already writing checks in drug discovery.

See all 12 investors →

Frequently asked

How much has Hemab Therapeutics Holdings raised?
Hemab Therapeutics Holdings has raised $355.1M in total across 2 recorded funding rounds.
When was Hemab Therapeutics Holdings's last funding round?
Hemab Therapeutics Holdings's most recent recorded round was Later Stage VC (Series C) in Oct 2025, raising $157.0M.